{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:13Z","timestamp":1793600773458,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100032196","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbrc.2026.153660","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:09:39Z","timestamp":1774544979000},"page":"153660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In silico and in vitro analysis: Unveiling the therapeutic potential of flavonoids against KLF7 in ovarian cancer"],"prefix":"10.1016","volume":"815","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1328-1413","authenticated-orcid":false,"given":"Kartik","family":"Bhatnagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Shandilay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-1534","authenticated-orcid":false,"given":"Arun Kumar","family":"Malaisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel Sarovar","family":"Bhavesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-7017","authenticated-orcid":false,"given":"Sarika","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153660_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153660_bib2","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153660_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14737159.2023.2168190","article-title":"The expression and mutation of BRCA1\/2 genes in ovarian cancer: a global systematic study","volume":"23","author":"Chu","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.bbrc.2026.153660_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153660_bib5","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.21873\/anticanres.13417","article-title":"Targeted genomic sequencing reveals novel TP53 In-frame deletion mutations leading to p53 overexpression in high-grade serous tubo-ovarian carcinoma","volume":"39","author":"Jung","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810892","article-title":"Sequential targeting of PLK1 and PARP1 reverses the resistance to PARP inhibitors and enhances platin-based chemotherapy in BRCA-deficient high-grade serous ovarian cancer with KRAS amplification","volume":"23","author":"Gasimli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153660_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1309\/AJCPZ5T2POOFMQVN","article-title":"Distinct \u03b2-Catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas","volume":"144","author":"Matsumoto","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbrc.2026.153660_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells13040345","article-title":"Complexity of the genetic background of oncogenesis in ovarian cancer\u2014genetic instability and clinical implications","volume":"13","author":"Murawski","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153660_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1872-2075(08)60042-4","article-title":"Computational and structural investigation of deleterious functional SNPs in breast cancer BRCA2 gene","volume":"24","author":"Rajasekaran","year":"2008","journal-title":"Chin. J. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153660_bib10","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153660_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12032-017-0960-z","article-title":"A brief review of the management of platinum-resistant\u2013platinum-refractory ovarian cancer","volume":"34","author":"Oronsky","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2026.153660_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14236010","article-title":"Cytoreductive surgery (CRS) and HIPEC for advanced ovarian cancer with peritoneal metastases: italian PSM oncoteam evidence and study purposes","volume":"14","author":"Marrelli","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153660_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00018-018-2954-1","article-title":"Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells","volume":"76","author":"Miku\u0142a-Pietrasik","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153660_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S1470-2045(11)70123-1","article-title":"Evolution of platinum resistance in high-grade serous ovarian cancer","volume":"12","author":"Cooke","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2026.153660_bib15","article-title":"A comprehensive analysis of transcription factors identified TCF3 as a prognostic target for glioma","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153660_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2023.12.001","article-title":"Deregulated transcription factors in the emerging cancer hallmarks","volume":"98","author":"Hasan","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.153660_bib17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.semcancer.2022.10.001","article-title":"Deregulated transcription factors in cancer cell metabolisms and reprogramming","volume":"86","author":"Kant","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.153660_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153660_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153660_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc3582","article-title":"Kr\u00fcppel-like factors in cancer","volume":"13","author":"Tetreault","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.153660_bib21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41467-019-09116-x","article-title":"A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma","volume":"10","author":"Syafruddin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153660_bib22","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1073\/pnas.2005156117","article-title":"KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining golgi complex integrity","volume":"117","author":"Gupta","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.153660_bib23","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-04-3619","article-title":"Drastic down-regulation of kruppel-like factor 4 expression is critical in human gastric cancer development and progression","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12935-020-1133-2","article-title":"miR-450b-3p inhibited the proliferation of gastric cancer via regulating KLF7","volume":"20","author":"Yao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.153660_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.canlet.2019.09.012","article-title":"ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4","volume":"467","author":"Zou","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153660_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacbts.2017.09.001","article-title":"Kr\u00fcppel-like factors: crippling and un-crippling metabolic pathways","volume":"3","author":"Pollak","year":"2018","journal-title":"JACC, Basic Transl. Sci."},{"key":"10.1016\/j.bbrc.2026.153660_bib27","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/j.gastro.2017.03.035","article-title":"SP and KLF transcription factors in digestive physiology and diseases","volume":"152","author":"Kim","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153660_bib28","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2020_5680","article-title":"Kr\u00fcppel-like factor 1 serves as a facilitator in gastric cancer progression via activating the Wnt\/\u03b2-catenin pathway","author":"Li","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbrc.2026.153660_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.canlet.2019.11.012","article-title":"TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression","volume":"469","author":"He","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153660_bib30","doi-asserted-by":"crossref","DOI":"10.3892\/or.2018.6687","article-title":"KLF5 promotes the tumorigenesis and metastatic potential of thyroid cancer cells through the NF-\u03baB signaling pathway","author":"Ma","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.153660_bib31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4314\/tjpr.v20i7.5","article-title":"Suppression of KLF7 gene expression inhibits proliferation and induces apoptosis of hemangioma cells via NF-\u03baB signaling pathway","volume":"20","author":"Wu","year":"2022","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib32","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1073\/pnas.1120684109","article-title":"Kr\u00fcppel-like factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract","volume":"109","author":"Blackmore","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.153660_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3892\/ijmm.2020.4649","article-title":"MicroRNA-103 modulates tumor progression by targeting KLF7 in non-small cell lung cancer","volume":"46","author":"Li","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153660_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4149\/neo_2021_201208N1328","article-title":"microRNA-204 shuttled by mesenchymal stem cell-derived exosomes inhibits the migration and invasion of non-small-cell lung cancer cells via the KLF7\/AKT\/HIF-1\u03b1 axis","volume":"68","author":"Liu","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrc.2026.153660_bib35","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.yexcr.2010.05.021","article-title":"Transcription factor KLF7 regulates differentiation of neuroectodermal and mesodermal cell lineages","volume":"316","author":"Caiazzo","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-022-01562-8","article-title":"Kr\u00fcppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer","volume":"24","author":"L\u00fcchtenborg","year":"2022","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jss.2019.12.053","article-title":"High expression of kr\u00fcppel-like factor 7 indicates unfavorable clinical outcomes in patients with lung adenocarcinoma","volume":"250","author":"Niu","year":"2020","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1159\/000481748","article-title":"Kr\u00fcppel-like factor 7 is a marker of aggressive gastric cancer and poor prognosis","volume":"43","author":"Jiang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2026.153660_bib39","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.2147\/CMAR.S308071","article-title":"KLF7 promotes gastric carcinogenesis through regulation of ANTXR1","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-020-01775-9","article-title":"KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer","volume":"39","author":"De Donato","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402479","article-title":"Phytochemicals in cancer therapy: a structured review of mechanisms, challenges, and progress in personalized treatment","volume":"22","author":"Aljabali","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bbrc.2026.153660_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ddc3010011","article-title":"Plant-derived natural products: a source for drug discovery and development","volume":"3","author":"Chaachouay","year":"2024","journal-title":"Drugs and Drug Candidates"},{"key":"10.1016\/j.bbrc.2026.153660_bib43","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbrc.2026.153660_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117739","article-title":"Licorice flavonoid ameliorates ethanol-induced gastric ulcer in rats by suppressing apoptosis via PI3K\/AKT signaling pathway","volume":"325","author":"Guo","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2026.153660_bib45","doi-asserted-by":"crossref","first-page":"23286","DOI":"10.1021\/acs.jafc.4c05945","article-title":"Enhanced SIRT1 activity by galangin mitigates UVB-induced senescence in dermal fibroblasts via p53 acetylation regulation and activation","volume":"72","author":"Wen","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2026.153660_bib46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/cells10040797","article-title":"Distinct classes of flavonoids and epigallocatechin gallate, polyphenol affects an oncogenic mutant p53 protein, cell growth and invasion in a TNBC breast cancer cell line","volume":"10","author":"Kollareddy","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153660_bib47","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3390\/molecules27123782","article-title":"Scutellarein inhibits LPS-induced inflammation through NF-\u03baB\/MAPKs signaling pathway in RAW264.7 cells","volume":"27","author":"Park","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153660_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/13880209.2025.2488135","article-title":"Total flavonoids of litchi seed inhibit breast cancer metastasis by regulating the PI3K\/AKT\/mTOR and MAPKs signaling pathways","volume":"63","author":"Yang","year":"2025","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bbrc.2026.153660_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139468","article-title":"Integrating network pharmacology to investigate the mechanism of quercetin's action through AKT inhibition in co-expressed genes associated with polycystic ovary syndrome and endometrial cancer","volume":"297","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153660_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114350","article-title":"Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA\/YAP axis","volume":"160","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153660_bib51","article-title":"Apigenin inhibits the histamine-induced proliferation of ovarian cancer cells by downregulating ER\u03b1\/ER\u03b2 expression","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153660_bib52","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2018.9250","article-title":"Luteolin inhibits angiogenesis of the M2-like TAMs via the downregulation of hypoxia inducible factor-1\u03b1 and the STAT3 signalling pathway under hypoxia","author":"Fang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.153660_bib53","article-title":"Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1\u03b1 and P-gp in the human pancreatic carcinoma cell line PANC-1, Oncol","author":"Zhao","year":"2012","journal-title":"Rep"},{"key":"10.1016\/j.bbrc.2026.153660_bib54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10495-012-0719-0","article-title":"Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer","volume":"17","author":"Kim","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2026.153660_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41397-025-00368-z","article-title":"Meta-analysis and review of in silico methods in drug discovery \u2013 part 1: technological evolution and trends from big data to chemical space","volume":"25","author":"Uzundurukan","year":"2025","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bbrc.2026.153660_bib56","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00044-024-03260-w","article-title":"In silico drug discovery: a machine learning-driven systematic review","volume":"33","author":"Atasever","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/756134","article-title":"AKT Kinase pathway: a leading target in cancer research","volume":"2013","author":"Kumar","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.bbrc.2026.153660_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12013-013-9524-9","article-title":"Computational investigation of cancer-associated molecular mechanism in Aurora A (S155R) mutation","volume":"66","author":"Kumar","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2026.153660_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00923","article-title":"Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview","volume":"9","author":"Salmaso","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153660_bib60","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ygeno.2020.10.001","article-title":"Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants","volume":"113","author":"Singh","year":"2021","journal-title":"Genomics"},{"key":"10.1016\/j.bbrc.2026.153660_bib61","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1080\/07391102.2021.1900918","article-title":"Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration","volume":"40","author":"Singh","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.153660_bib62","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1080\/07391102.2020.1772109","article-title":"Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation","volume":"39","author":"Bhardwaj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.153660_bib63","doi-asserted-by":"crossref","first-page":"15293","DOI":"10.1007\/s13277-016-5329-y","article-title":"Impact of point mutation P29S in RAC1 on tumorigenesis","volume":"37","author":"Rajendran","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbrc.2026.153660_bib64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/cbdd.13446","article-title":"Suitability of <scp>MMGBSA<\/scp> for the selection of correct ligand binding modes from docking results","volume":"93","author":"Ahinko","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2026.153660_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151701","article-title":"Hunting potential SIRT2 inhibitors towards cancer treatment: drug repurposing, molecular dynamics, and binding energy computations","volume":"760","author":"Ibrahim","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153660_bib66","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib67","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the universal protein Knowledgebase in 2025","volume":"53","author":"Bateman","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib68","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib69","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2026.153660_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bbrc.2026.153660_bib71","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrc.2026.153660_bib72","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem Substance and Compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153660_bib73","author":"Dallakyan"},{"key":"10.1016\/j.bbrc.2026.153660_bib74","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.153660_bib75","series-title":"The Pymol Molecular Graphics System","year":"2025"},{"key":"10.1016\/j.bbrc.2026.153660_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.601065","article-title":"RASPD+: fast protein-ligand binding free energy prediction using simplified physicochemical features","volume":"7","author":"Holderbach","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2026.153660_bib77","series-title":"Qikprop, Version v.6.8","author":"Schr\u00f6dinger","year":"2024"},{"key":"10.1016\/j.bbrc.2026.153660_bib78","series-title":"Schr\u00f6dinger Release 2024-4","year":"2024"},{"key":"10.1016\/j.bbrc.2026.153660_bib79","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/15384101.2015.1127469","article-title":"Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication","volume":"15","author":"De Santis Puzzonia","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.153660_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-024-03826-w","article-title":"Promising new drugs and therapeutic approaches for treatment of ovarian cancer\u2014targeting the hallmarks of cancer","volume":"23","author":"Hillmann","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.bbrc.2026.153660_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.195003","article-title":"Modulation of Kr\u00fcppel-like factors (KLFs) interaction with their binding partners in cancers through acetylation and phosphorylation","volume":"1867","author":"Jha","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:29:25Z","timestamp":1793597365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26004249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":81,"alternative-id":["S0006291X26004249"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153660","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and in vitro analysis: Unveiling the therapeutic potential of flavonoids against KLF7 in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153660"}}